Using generative AI, Suki Assistant Gen 2 will generate notes ambiently and take dictation and commands all in a single, affordable solution. It’s the first ambient documentation solution that fully integrates with major EHRs.
REDWOOD CITY, CALIF. — April 11, 2023 —Suki, the leader in voice artificial intelligence (AI) technology for healthcare, announced today Suki Assistant Gen 2, which adds the revolutionary capability to automatically generate notes from listening to a clinician-patient conversation. Called ambient note generation, this new feature will be added to the company’s flagship AI voice assistant. Suki Assistant Gen 2 is differentiated in the market by a comprehensive set of capabilities, including ambient note generation, dictation and command functionality, all within a single, affordable, scalable solution that fully integrates with commonly used EHR systems including Epic, Cerner, Athena, and Elation.
Suki Assistant Gen 2 makes use of generative AI to listen to physician-patient interactions in real-time and auto generate clinical notes—without requiring human intervention in the background. Clinicians can easily accept, reject, or edit content suggestions to ensure accuracy of final notes.
Users can pick and choose how they interact with Suki Assistant. For example, if the preference is to use ambient in some encounters while dictating into the solution in others, switching between the two options is easy. Users can also ask Suki information about their patients, such as what medications they are taking or what allergies they have, and get recommendations for diagnosis codes.
"Suki Assistant accommodates ambient, dictation, and command modes in a single solution, which is a unique differentiator. Clinicians want the freedom and flexibility to adjust their workflows, not be locked into rigid processes. Suki’s approach allows organizations to provide this flexibility in a single application that in the past would have required 2-3 separate tools. It’s a very exciting evolution, and one that I believe will be very compelling to health systems, practices, and clinicians across the board," said Jack Bretcher, Chief Operating Officer of PartnerMD, a leader in concierge medicine with a network of practices across the Mid-Atlantic and Southeast.
Suki Assistant Gen 2 builds on the existing assistant’s proven ability to reduce documentation time per note by as much as 72% in family medicine settings to address unprecedented burnout among physicians. A study in Mayo Proceedings showed 63% of physicians reported at least one burnout symptom, while in another survey, 60% attribute burnout to administrative demands.
“We are in a golden age for AI. With Suki Assistant Gen 2, we are bringing the most sophisticated AI voice assistant to the market. The introduction of this solution could not be more timely as burnout—much of which is directly related to administrative burden—is pushing physicians to leave medicine at a time when we need them most,” said Punit Soni, CEO of Suki. “We are excited to bring innovation to the market that delivers tremendous value for users by giving them a full array of AI and voice functionality in one solution. Suki is the only solution that fully integrates with all major EHRs, with clinical notes and ICD-10 codes synchronized in real time to the systems of record. Finally, Suki’s tech-driven approach also makes us the most affordable voice assistant on the market, making Suki a natural choice for helping clinicians find joy in medicine again.”
Suki Assistant Gen 2 will be available for beta testing in late April. To join the waitlist for priority access, visit suki.ai.
Suki is a leading technology company that provides AI-powered voice solutions for healthcare. Its mission is to reimagine the healthcare tech stack, making it invisible and assistive to lift the administrative burden from physicians. Its flagship product is Suki Assistant, an AI-powered, voice enabled digital assistant that helps physicians complete documentation and other administrative tasks 72% faster on average. Suki also offers its proprietary voice platform, Suki Speech Platform (SSP), to partners who want to create a best-in-class voice experience for their solutions. SSP uses the latest in natural language processing and machine learning to provide industry-leading accuracy and natural and fast voice experience. Suki is backed by investors including Venrock, First Round, Flare Capital Partners, March Capital, and Breyer Capital. To learn more, visit suki.ai, or follow us on LinkedIn and Twitter.